National Institute of Environmental Health Sciences; Notice of Meeting, 67748-67749 [2011-28379]
Download as PDF
<![CDATA[
emcdonald on DSK5VPTVN1PROD with NOTICES
67748
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Notices
nominations and other sources as
needed to meet statutory requirements
and to form a balanced committee that
represents the diversity within the
community (details below). Those
eligible for nomination include leaders
or representatives of major autism
spectrum disorder (ASD) research,
advocacy and service organizations,
parents or guardians of individuals with
ASD, individuals on the autism
spectrum, providers, educators,
researchers and other individuals with
professional or personal experience
with ASD. In accordance with White
House Office of Management and
Budget guidelines (FR Doc. 2011–
25736), federally-registered lobbyists are
not eligible. As specified in Public Law
109–416, which has been extended by
Public Law 112–32, the Committee will
carry out the following responsibilities:
(a) Develop a summary of advances in
autism spectrum disorder research
supported or conducted by the Federal
agencies relevant to causes, prevention,
treatment, early screening, diagnosis or
rule out, intervention, and access to
services and supports for individuals
with autism spectrum disorder; (b)
monitor Federal activities with respect
to autism spectrum disorder; (c) make
recommendations to the Secretary
regarding any appropriate changes to
such activities, including
recommendations to the Director of NIH
with respect to the strategic plan; (d)
make recommendations to the Secretary
regarding public participation in
decisions relating to autism spectrum
disorder; (e) develop and annually
update a strategic plan for the conduct
of, and support for, autism spectrum
disorder research, including proposed
budgetary requirements.
In accordance with Public Law 109–
416, which has been extended by Public
Law 112–32, ‘‘Not fewer than 6
members of the Committee, or 1/3 of the
total membership of the Committee,
whichever is greater, shall be composed
of non-Federal public members
appointed by the Secretary, of which—
(a) at least one such member shall be an
individual with a diagnosis of autism
spectrum disorder; (b) at least one such
member shall be a parent or legal
guardian of an individual with an
autism spectrum disorder; and (c) at
least one such member shall be a
representative of leading research,
advocacy, and service organizations for
individuals with autism spectrum
disorder.’’
Public members of the Committee
shall serve for a term of 4 years, and
may be reappointed for one or more
additional 4 year terms. Any member
appointed to fill a vacancy for an
VerDate Mar<15>2010
19:21 Nov 01, 2011
Jkt 226001
unexpired term shall be appointed for
the remainder of such term. A member
may serve after the expiration of the
member’s term until a successor has
taken office. Public members will serve
as Special Government Employees. The
Committee shall meet at the call of the
chairperson or upon the request of the
Secretary. The Committee shall meet not
fewer than 2 times each year.
In 2008–2011, the Committee held an
average of 15 meetings, workshops and
phone conferences per year. Travel
expenses are provided for Committee
members to facilitate attendance at inperson meetings.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of women, all ethnic and racial groups,
and people with disabilities are
represented on HHS Federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. Requests for
reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission. Nominations are due by
COB November 30, 2011 and may be
sent to Dr. Susan Daniels, Acting
Director, Office of Autism Research
Coordination/NIMH/NIH, 6001
Executive Boulevard, Room 8185,
Bethesda MD 20892–2190 by standard
or express mail, or via email to
IACCPublicInquiries@mail.nih.gov.
Nominations should include a cover
letter of no longer than 3 pages
describing the candidate’s interest in
seeking appointment to the IACC,
including relevant personal and
professional experience with ASD, as
well as contact information and a
current curriculum vitae or resume.
Please do not include additional
materials unless requested. More
information about the IACC is available
at https://www.iacc.hhs.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 27, 2011.
Susan A. Daniels,
Acting Director, Office of Autism Research
Coordination, National Institute of Mental
Health.
National Institutes of Health
[FR Doc. 2011–28375 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special:
Pilot and Feasibility Clinical Research
Studies in Digestive. Diseases and Nutrition.
Date: November 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road.
Bethesda, MD 20852.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–28370 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\02NON1.SGM
02NON1
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Notices
emcdonald on DSK5VPTVN1PROD with NOTICES
hereby given of a meeting of the
Interagency Breast Cancer and
Environmental Research Coordinating
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Interagency Breast
Cancer and Environmental Research
Coordinating, Committee (IBCERC), Research
Process Subcommittee.
Date: December 12, 2011.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: The purpose of the meeting is to
continue the work of the Research Process
Subcommittee as it addresses a broad set of
objectives related to the overall mandate of
the IBCERC including: setting research
priorities, decreasing redundancies across
federal and non-governmental organizations,
developing a process for soliciting research,
fostering collaborations, highlighting peer
review issues, and identifying the most
appropriate models for agencies to work
together. The meeting agenda will be
available on the Web at https://
www.niehs.nih.gov/about/orgstructure/
boards/ibcercc/.
Place: NIEHS/National Institutes of Health,
Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709 (Telephone Conference Call).
Contact Person: Gwen W. Collman, Ph.D.,
Director, Division of Extramural Research
and Training, Nat. Inst. of Environmental
Health Sciences, National Institutes of
Health, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541–
4980, collman@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–28379 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
19:21 Nov 01, 2011
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR11–107
Ancillary Studies to the NIDDK Intestinal
Stem Cell Consortium (ISCC).
Date: December 1, 2011.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–28378 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
67749
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH/PEPFAR Collaboration
for Implementation Science and Impact
Evaluation.
Date: December 2, 2011.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, (301)
402–6891, poonb@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH/PEPFAR Collaboration
for Implementation Science and Impact
Evaluation.
Date: December 16, 2011.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, (301)
402–6891, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–28377 Filed 11–1–11; 8:45 am]
National Institute of Allergy And
Infectious Diseases; Notice of Closed
Meetings
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00082
Fmt 4703
Sfmt 9990
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 76, Number 212 (Wednesday, November 2, 2011)]
[Notices]
[Pages 67748-67749]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28379]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Environmental Health Sciences; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 67749]]
hereby given of a meeting of the Interagency Breast Cancer and
Environmental Research Coordinating Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Interagency Breast Cancer and Environmental
Research Coordinating, Committee (IBCERC), Research Process
Subcommittee.
Date: December 12, 2011.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: The purpose of the meeting is to continue the work of
the Research Process Subcommittee as it addresses a broad set of
objectives related to the overall mandate of the IBCERC including:
setting research priorities, decreasing redundancies across federal
and non-governmental organizations, developing a process for
soliciting research, fostering collaborations, highlighting peer
review issues, and identifying the most appropriate models for
agencies to work together. The meeting agenda will be available on
the Web at https://www.niehs.nih.gov/about/orgstructure/boards/ibcercc/.
Place: NIEHS/National Institutes of Health, Building 4401, East
Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709
(Telephone Conference Call).
Contact Person: Gwen W. Collman, Ph.D., Director, Division of
Extramural Research and Training, Nat. Inst. of Environmental Health
Sciences, National Institutes of Health, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541-4980,
collman@niehs.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk Estimation--Health Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic
Research and Education; 93.894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research
and Testing, National Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-28379 Filed 11-1-11; 8:45 am]
BILLING CODE 4140-01-P
